TSRO Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -23.19 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -71.30M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 1.155B |
| Enterprise Value | 955.96M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 6.112 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -18.16M |
| Return on Equity | -65.38% |
TSRO News
- Are These Top Post-IPO Performers Still a Buy? Fool May 21
- Nasdaq stocks posting largest percentage increases May 20
- Cramer's 'Mad Money' Recap: Think Dividends, Not Coupons May 20
- The Best- And Worst- Performing Biotech Stocks, May 10 To May 17 May 19
- 3 Humongous Health-Care Stocks This Week Fool May 18
- 4 Healthcare Stock Stories For Thursday Investing Wellness May 16
- Nasdaq stocks posting largest percentage increases May 16
- Why Tesaro Shares Vaulted Higher Fool May 16
- TESARO rises after data support advancement of drug to Phase 3 trials May 16
- Tesaro Final Phase 1 Results Demonstrate Activity in Ovarian and Breast Cancer, ... May 16
TSRO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Tesaro is up 0.99% over the last year vs S&P 500 Total Return up 31.95%, Halozyme Therapeutics down 3.99%, and Oramed Pharmaceuticals down 96.83%.
TSRO Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these TSRO related companies
Pro Ratings for TSRO
Pro Report PDF for TSRO
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download TSRO Pro Report PDF
Pro Strategies Featuring TSRO
Did Tesaro make it into our Pro Portfolio Strategies?
TSRO Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Other TSRO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TSRO | 35.85 | +0.35 | +0.99% | 1.155B |
